Back to User profile » Dr Alexander Drilon

Papers published by Dr Alexander Drilon:

Review

Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors

Liu D, Offin M, Harnicar S, Li BT, Drilon A

Therapeutics and Clinical Risk Management 2018, 14:1247-1252

Published Date: 20 July 2018

Review

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A

OncoTargets and Therapy 2017, 10:1983-1992

Published Date: 6 April 2017